Omnicell Inc (OMCL)
30.25
-0.03
(-0.10%)
USD |
NASDAQ |
May 15, 14:51
Omnicell Cash from Investing (Quarterly): -12.34M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.34M |
| December 31, 2023 | -12.37M |
| September 30, 2023 | -14.19M |
| June 30, 2023 | -14.82M |
| March 31, 2023 | -13.64M |
| December 31, 2022 | -17.25M |
| September 30, 2022 | -15.87M |
| June 30, 2022 | -6.817M |
| March 31, 2022 | -18.73M |
| December 31, 2021 | -192.38M |
| September 30, 2021 | -193.63M |
| June 30, 2021 | -13.35M |
| March 31, 2021 | -13.13M |
| December 31, 2020 | -236.69M |
| September 30, 2020 | -9.961M |
| June 30, 2020 | -19.44M |
| March 31, 2020 | -13.78M |
| December 31, 2019 | -14.90M |
| September 30, 2019 | -14.81M |
| June 30, 2019 | -15.25M |
| March 31, 2019 | -16.70M |
| December 31, 2018 | -12.90M |
| September 30, 2018 | -13.40M |
| June 30, 2018 | -13.54M |
| March 31, 2018 | -14.54M |
| Date | Value |
|---|---|
| December 31, 2017 | -10.89M |
| September 30, 2017 | -6.254M |
| June 30, 2017 | -11.01M |
| March 31, 2017 | -6.837M |
| December 31, 2016 | -47.98M |
| September 30, 2016 | -8.081M |
| June 30, 2016 | -5.399M |
| March 31, 2016 | -279.86M |
| December 31, 2015 | -4.284M |
| September 30, 2015 | -7.571M |
| June 30, 2015 | -29.63M |
| March 31, 2015 | -4.108M |
| December 31, 2014 | -5.264M |
| September 30, 2014 | -25.03M |
| June 30, 2014 | -7.441M |
| March 31, 2014 | -5.592M |
| December 31, 2013 | -6.716M |
| September 30, 2013 | -4.767M |
| June 30, 2013 | -3.722M |
| March 31, 2013 | -5.247M |
| December 31, 2012 | -7.54M |
| September 30, 2012 | -7.231M |
| June 30, 2012 | -152.41M |
| March 31, 2012 | -1.528M |
| December 31, 2011 | -2.645M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-236.69M
Minimum
Dec 2020
-6.817M
Maximum
Jun 2022
-43.17M
Average
-14.81M
Median
Cash from Investing (Quarterly) Benchmarks
| Teladoc Health Inc | -35.51M |
| American Shared Hospital Services | -0.097M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -71.04M |
| Cryo-Cell International Inc | -0.341M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 49.95M |
| Cash from Financing (Quarterly) | 11.93M |
| Free Cash Flow | 164.56M |
| Free Cash Flow Per Share (Quarterly) | 0.8225 |
| Free Cash Flow to Equity (Quarterly) | 36.84M |
| Free Cash Flow to Firm (Quarterly) | 37.61M |
| Free Cash Flow Yield | 11.94% |